Literature DB >> 6252867

Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.

S Alenius.   

Abstract

The effects of adenine arabinoside, cytosine arabinoside, iododeoxyuridine, ribavirin, phosphonoacetate and phosphonoformate on virus titers in cutaneous herpesvirus infections of guinea pigs have been determined and compared to their effects on lesion score. Only phosphonoacetate and phosphonoformate caused a reduction in virus titer and lesion score when the drugs were applied topically after symptoms had developed. However, unlike phosphonoacetate, phosphonoformate did not cause local skin irritation. A herpesvirus mutant, inducing a DNA polymerase resistent to phosphonoformate gave rise to an infection in which the virus titer was not reduced by phsophonoformate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252867     DOI: 10.1007/bf01317326

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

1.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model.

Authors:  S R Harris; M R Boyd
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

3.  The natural history of recurrent facial-oral infection with herpes simplex virus.

Authors:  C Bader; C S Crumpacker; L E Schnipper; B Ransil; J E Clark; K Arndt; I M Freedberg
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

4.  Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; Z Dinter; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Guinea pig model for cutaneous herpes simplex virus infection.

Authors:  W R Hubler; T D Felber; D Troll; M Jarratt
Journal:  J Invest Dermatol       Date:  1974-02       Impact factor: 8.551

6.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

7.  Cutaneous herpes simplex virus infection of guinea pigs as a model for antiviral chemotherapy.

Authors:  T W Schafer; M Lieberman; J Everitt; P Came
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

8.  The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.

Authors:  S L Spruance; J C Overall; E R Kern; G G Krueger; V Pliam; W Miller
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

9.  Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; B Oberg
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

10.  Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.

Authors:  B Eriksson; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.